Skip to main content

Year: 2023

Traction Uranium Announces Closing of the Second Tranche of Private Placement

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, Nov. 24, 2023 (GLOBE NEWSWIRE) — Traction Uranium Corp. (CSE: TRAC) (OTCQB: TRCTF) (FRA: Z1K) (the “Company” or “Traction”) is pleased to announce that, further to its news release of October 27, 2023 and November 14, 2023 which announced: i.) a private placement offering (the “Offering”) of up to 10,000,000 non-flow through units (“NFT”) and up to 5,714,285 flow-through (“FT”) units, as well as, ii.) the closing of the first tranche of the Offering, respectively, it has closed the second tranche of the Offering (the “Second Tranche”) by issuing 2,000,000 FT units (each, an “FT Unit”) at a price of $0.175 per FT Unit, for aggregate gross proceeds of $350,000. Each FT Unit consisted of one (1) “flow-through”...

Continue reading

Orezone Files Bomboré Phase II Expansion Study Technical Report

VANCOUVER, British Columbia, Nov. 24, 2023 (GLOBE NEWSWIRE) — Orezone Gold Corporation (TSX: ORE, OTCQX: ORZCF) (“Orezone” or “Company”) announces that, further to its news release dated October 11, 2023, the Company has filed an independent National Instrument 43-101 technical report entitled “Bomboré Phase II Expansion, Definitive Feasibility Study” (the “FS”). A copy of the FS is available on SEDAR+ and the Company’s website. The FS was prepared for Orezone by personnel from Lycopodium Mineral Canada Ltd. and other industry consultants, each of whom is a “qualified person” within the meaning of NI 43-101 and considered to be “independent” of the Company under Section 1.5 of NI 43-101. About Orezone Gold Corporation Orezone Gold Corporation (TSX: ORE OTCQX: ORZCF) is a Canadian mining company operating...

Continue reading

VILNIAUS BALDAI AB annual audited information for the year 2023

Please find attached VILNIAUS BALDAI AB audited consolidated and company’s financial statements for the year 2023 ended 31 August 2023 with independent auditor’s report. Enclosed: Independent auditor’s report, consolidated annual report, consolidated and company’s financial statements for the year 2023 ended 31 August 2023. Additional information: General manager Jonas Krutinis Phone No: +370 5 2525700Attachmentsabvilniausbaldai-2023-08-31-enCONSOLIDATED AND COMPANY’S FINANCIAL STATEMENTS FOR THE FY 2023 ENDED 31 AUGUST 2023

Continue reading

HPQ Silicon Inc.: Final Closing of Financing

MONTREAL, Nov. 24, 2023 (GLOBE NEWSWIRE) — HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ) (OTCQB: HPQFF) (FRA: O08), a technology company specializing in green engineering processes for silica and silicon material production is pleased to inform shareholders that it closed the its Non-Brokered Private placement financing announced on October 16, 2023. In addition to the 1,225,500 units as announced on November 16, 2023, the company announces the closing of additional 981,818 units at a price of $ 0.275 per unit for a gross proceed of $ 269,999.94, bringing the total amount raised at $ 607,012.44 and the total number of units issued at 2,207,318. “Successfully raising more than $ 600,000 at a premium of almost 9% to market, in these less-than-ideal market conditions, is another demonstration of the interest in the HPQ value...

Continue reading

Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing

FLORHAM PARK, N.J., Nov. 24, 2023 (GLOBE NEWSWIRE) — Celularity Inc. (Nasdaq: CELU) (the “Company”), a biotechnology company developing allogeneic cell therapies and biomaterial products, announced today that on November 21, 2023, the Company received notification from the Listing Qualifications department of the Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company is not in compliance with Nasdaq’s continued listing requirements of the Company’s failure to timely file a Form 10-Q for the third quarter of 2023. The Company is required to submit to Nasdaq a plan to regain compliance within 60 calendar days, or by January 22, 2024, and if accepted, the Company has a period of 180 calendar days from the Q3 2023 Form 10-Q due date, or until May 20, 2024, to implement the plan to regain compliance. The Company intends to submit...

Continue reading

Gain Therapeutics Announces Closing of $10.1 Million Public Offering and Concurrent Private Placement of Common Stock and Warrants, Including Full Exercise of Over-Allotment Option

BETHESDA, Md., Nov. 24, 2023 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc. (“Gain” or the “Company”) (Nasdaq: GANX) today announced the closing of an underwritten public offering of 2,545,000 shares of its common stock and warrants to purchase up to an aggregate of 1,272,500 shares of its common stock at a combined public offering price of $2.005 per share and accompanying warrant, including 331,956 shares of common stock and warrants to purchase 165,978 shares of common stock issued pursuant to the full exercise by the underwriter of its over-allotment option. The public offering price for each set of two shares of common stock and accompanying warrant to purchase one share of common stock was $4.01 per set of securities, yielding an effective price of $2.00 per share and $0.01 per warrant. The warrants were sold at the rate of one...

Continue reading

Innofactor Plc: Share Repurchase 24.11.2023

Innofactor Plc Announcement 24.11.2023          Innofactor Plc: Share Repurchase 24.11.2023       In the Helsinki Stock Exchange         Trade date 24.11.2023  Bourse trade Buy  Share IFA1V  Amount 4,600 SharesAverage price/ share 1.1349 EURTotal cost 5,220.54 EUR          Innofactor Plc now holds a total of 538 529 sharesincluding the shares repurchased on 24.11.2023          On behalf of Innofactor Plc         Nordea Bank Oyj         Janne Sarvikivi Sami Huttunen       Additional information:    Sami Ensio, CEO    Innofactor Plc    Tel. +358 50 584 2029    sami.ensio@innofactor.com         www.innofactor.com       AttachmentInnofactor_24.11_trades

Continue reading

Vantiva: Notification of availability of the fairness opinion report

Press Release     Notification of availability of the fairness opinion report Paris – November 24th, 2023 – Vantiva (Euronext Paris: VANTI), Vantiva announces that on November 24, 2023, it made available to the public the fairness opinion report on the financial terms of the acquisition of CommScope’s Home Networks business, issued by the independent expert RSM appointed by the board of Directors.This report is available on the company’s website in the “Regulated Information” and “Shareholder’s Meeting” sections. About Vantiva Pushing the Edge Vantiva shares are admitted to trading on the regulated market of Euronext Paris (VANTI). Vantiva, formerly known as Technicolor, is headquartered in Paris, France. It is an independent company which is a global technology leader in designing, developing and supplying innovative products...

Continue reading

RCI Banque discloses Capital Requirements following the 2023 SREP draft decision

                                  November 24, 2023 RCI Banque discloses Capital Requirements following the 2023 SREP draft decision As part of the 2023 exercise of the supervisory review and evaluation process (“SREP”), the European Central Bank has notified RCI Banque of its draft decision regarding the capital requirement the Bank must respect in 2024. As of January 1, 2024*, the Pillar 2 requirement (P2R) will be 2.00% compared to 2.01% in January 2023. RCI Banque did not exercise its “right to be heard” and no major change is expected in the final decision. Starting from January 1, 2024*, RCI Banque will be required to meet the following capital requirements:    Minimum capital requirements  Total Pillar 1 Pillar 21 Buffers2CET13   11.33% 6.30% 2.00% 3.02%ow CET1 (Regulatory)   8.65% 4.50% 1.13% 3.02%ow...

Continue reading

Renault Group: Information relating to the total number of voting rights and share capital – October 2023

Disclosure of the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the French Commercial Code and the Article 223-16 of the Règlement général de l’Autorité des marchés financiers  (Regulation of the French stock market authority) Company name of the issuer:         Renault SA 122 – 122 bis Avenue du Général Leclerc 92100 Boulogne-Billancourt (ISIN code FR0000131906 – RNO)Date   Total number of issued shares     Total number of voting rightsOctober 31, 2023     295,722,284     Theoretical number of voting rights(1) : 400,901,717  Exercisable number of voting rights(2) : 304,963,149(1)   Pursuant to Article 223-11 of the Règlement général de l’Autorité des marchés financiers, number calculated on the basis of all shares to which voting rights are attached, including shares for which...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.